The relationship of peripheral blood lncRNA-PVT1 and miR-146a levels with Th17/Treg cytokines in patients with Hashimoto's thyroiditis and their clinical significance
- PMID: 38761409
- PMCID: PMC11379023
- DOI: 10.17305/bb.2024.10237
The relationship of peripheral blood lncRNA-PVT1 and miR-146a levels with Th17/Treg cytokines in patients with Hashimoto's thyroiditis and their clinical significance
Abstract
Hashimoto's thyroiditis (HT) is a prevalent autoimmune disease. We investigated the relationship of peripheral blood long noncoding RNA-plasmacytoma variant translocation 1 (lncRNA-PVT1) and microRNA (miR)-146a levels with Th17/Treg-related cytokines in HT patients and their clinical significance. Correlations of PVT1 and miR-146a with Th17/Treg-related cytokines were analyzed, and its clinical value in diagnosing HT was assessed. Results showed reduced lncRNA-PVT1 and interleukin (IL)-10 levels and increased miR-146a and IL-17 levels in HT patients. lncRNA-PVT1 negatively interrelated with miR-146a, IL-17, IL-23 and IL-6, and positively interrelated with IL-10; miR-146a positively correlated with IL-17, IL-23 and IL-6, but negatively correlated with IL-10 in HT patients. The area under the curve (AUC) of lncRNA-PVT1 and miR-146a levels for diagnosing HT were 0.822 and 0.844, respectively (sensitivity 88.73% and 86.62%, specificity 67.02% and 69.15%, cut-off values 0.76 and 2.73), with their combined detections yielding a higher AUC. Patients with poorly expressed lncRNA-PVT1 and highly expressed miR-146a had elevated HT incidence. lncRNA-PVT1 and miR-146a levels were also found to be an independent influencing factor for HT occurrence. Our findings suggest that HT patients have low peripheral blood lncRNA-PVT1 expression and high miR-146a expression. lncRNA-PVT1 and miR-146a level changes were correlated with Th17/Treg cytokine imbalance and could be a potential diagnostic tool and independent influencing factor for HT.
Conflict of interest statement
Conflicts of interest: Authors declare no conflicts of interest.
Figures
References
-
- Mikulska AA, Karazniewicz-Lada M, Filipowicz D, Ruchala M, Glówka FK. Metabolic characteristics of Hashimoto’s thyroiditis patients and the role of microelements and diet in the disease management—an overview. Int J Mol Sci. 2022 Jun 13;23(12):35743024. https://doi.org/10.3390/ijms23126580. - PMC - PubMed
-
- Ihnatowicz P, Drywien M, Wator P, Wojsiat J. The importance of nutritional factors and dietary management of Hashimoto’s thyroiditis. Ann Agric Environ Med. 2020 Jun 19;27(2):184–93. https://doi.org/10.26444/aaem/112331. - PubMed
-
- Li Y, Shen D, Wang K, Xue Y, Liu J, Li S, et al. Mogroside V ameliorates broiler pulmonary inflammation via modulating lung microbiota and rectifying Th17/Treg dysregulation in lipopolysaccharides-induced lung injury. Poult Sci. 2023 Dec;102(12):103138. https://doi.org/10.1016/j.psj.2023.103138. - PMC - PubMed
-
- Liu Y, Tang X, Tian J, Zhu C, Peng H, Rui K, et al. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto’s thyroiditis. Int J Mol Sci. 2014 Nov 25;15(12):21674–86. https://doi.org/10.3390/ijms151221674. - PMC - PubMed
-
- Mazzieri A, Montanucci P, Basta G, Calafiore R. The role behind the scenes of Tregs and Th17s in Hashimoto’s thyroiditis: toward a pivotal role of FOXP3 and BACH2. Front Immunol. 2022;13:1098243. https://doi.org/10.3389/fimmu.2022.1098243. - PMC - PubMed
